News & Press

  • Jul 13, 2015

    Evidence from Administration to Werner Syndrome Patients

    Evidence from Administration to Werner Syndrome Patients - AstaReal astaxanthin show promise to inhibit NAFLD/Hepatic Steatosis AstaReal® astaxanthin significantly improved NAFLD in patients with Werner syndrome, known as progeria, in a clinical study conducted by the Department of Clinical Cell Biology and Medicine, Graduate School of Medicine, Chiba University (Prof. Kotaro Yokote), which was published in the Journal of American Geriatrics Society (JAGS:June 2015, Vol. 63, No.6, 1271-1273). Click here to read full article.